Pharmaceutical Supply chain Risk Assessment During COVID-19 Epidemic. Issue 10 (2022)

• Record Type: Journal Article
• Authors: BenAmor, W. Daoud; Labella, A.; Frikha, H. Moalla; López, L. Martínez
• Is Part Of: IFAC-PapersOnLine. Volume 55:Issue 10(2022)
• Page Start: 2203
• Page End: 2208
• Publication Date: 2022
• Subjects: Pharmaceutical supply chain -- risk assessment -- COVID-19 -- risk mitigation strategy -- 2-Tuple BWM -- ARAS -- 2-Tuple linguistic environment; Automatic control -- Periodicals; 629.805
• DOI: 10.1016/j.ifacol.2022.10.035
• Languages: English
• ISSNs: 2405-8963

Abstract

Abstract: The global health products supply chain is negatively influenced by the COVID-19 pandemic. Moreover, the risks in the pharmaceutical supply chain (PSC) have increased. Assessment and mitigation risks in PSC are essential issues to control and counter these risks. In this study, a 2-Tuple ARAS-BWM approach, which combines ARAS and BWM methods under linguistic 2-Tuple environment, is proposed to evaluate and address various risks to the best mitigation strategies in the pharmaceutical industry in Tunisia during COVID-19. Noted that the main risk identified in the PSC is related to supply and suppliers and its best mitigation strategy is reducing risk.